• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Pharma

Stamp with blue ink that says FDA Approved
Pharma

Novartis buffers price erosion with Cosentyx's 11th FDA nod

Cosentyx is now the first anti-IL-17 approved in polymyalgia rheumatica, a label expansion that could help Novartis stave off price erosion.
Donavyn Coffey Nov 17, 2026 2:00pm
Lung cancer

GSK snags FDA nod for 2nd lung cancer drug from Nuvalent deal

Nov 17, 2026 1:30pm
Podcast
lifesciencetoplinepodcastheroimageiqvia1png

Digital Twins: Advancing Clinical Evidence Strategy

Brought to you by IQVIA
justice gavel

AZ emerges victorious in lawsuit over Soliris antitrust claims

Nov 17, 2026 11:25am
video
Why AIs Biggest Value in Pharma Is Confidence

Why AI’s Biggest Value in Pharma Is Confidence

Brought to you by /prompt
Roche building

Roche’s next major breast cancer drug, Wilserdly, wins FDA nod

Nov 17, 2026 10:50am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings